The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
NCT06557304 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-08-21
Summary
This is a Multicenter, Retrospective Real-world Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China
Conditions
Interventions
- DRUG
-
BTK inhibitor
patients with treatment naive or R/R CLL who treatment with BTK inhibitor
Sponsors & Collaborators
-
Peking University People's Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2026-09-01
- Completion
- 2027-12-30
- FDA Drug
- Yes
More Related Trials
-
Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLL
NCT05287984 ·Status: UNKNOWN ·Phase: PHASE2
-
MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL
NCT06367374 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study
NCT07003464 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT05703204 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia
NCT03734016 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
NCT06341556 ·Status: RECRUITING ·Phase: PHASE2
-
Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
NCT04980859 ·Status: UNKNOWN ·Phase: PHASE3
-
Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT06547944 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
NCT03932331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies
NCT05269940 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
NCT07107204 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06544785 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
NCT07271667 ·Status: RECRUITING ·Phase: PHASE2
-
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
NCT06580301 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT05479994 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
NCT06054113 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
NCT06637501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies
NCT05944978 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
NCT02042911 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)
NCT05579132 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy
NCT06476899 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
NCT06697184 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Combination of Ibrutinib and As2O3 in the Treatment of CLL
NCT02757040 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL
NCT05272813 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)
NCT02140606 ·Status: UNKNOWN ·Phase: PHASE1